International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study

Harsh Chalana 1 , * , Tanu Kundal 1 and Amandeep Singh Malhari 1
Authors Information
1 Department of Psychiatry, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India
Article information
  • International Journal of High Risk Behaviors and Addiction: September 2017, 6 (3); e59543
  • Published Online: August 19, 2017
  • Article Type: Research Article
  • Received: August 23, 2016
  • Revised: October 7, 2016
  • Accepted: December 24, 2016
  • DOI: 10.5812/ijhrba.59543

To Cite: Chalana H, Kundal T, Singh Malhari A. Depression as a Risk Factor for Relapse After Inpatient Opioid Detoxification: 1-Year Follow-Up Study, Int J High Risk Behav Addict. 2017 ; 6(3):e59543. doi: 10.5812/ijhrba.59543.

Abstract
Copyright © 2017, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Strain EC, Lofwall MR, Jaffe JH. Kaplan & Sadock's Comprehensive textbook of psychiatry. 2000; : 1360-87
  • 2. Chalana H, Sachdeva JK, Kundal T, Malhari AS, Choudhary R. A Double - Blind, Placebo - Controlled, Randomized Study Comparing Quetiapine with Placebo, Along with Oral Naltrexone, in the Treatment of Opioid Dependent Patients. J Evol Med Dent Sci. 2015; 4(53): 9158-67[DOI]
  • 3. Koob GF, Maldonado R, Stinus L. Neural substrates of opiate withdrawal. Trends Neurosci. 1992; 15(5): 186-91[DOI]
  • 4. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997; 278(5335): 52-8[PubMed]
  • 5. Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol. 2008; 154(2): 261-74[DOI][PubMed]
  • 6. Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005; 3(1): 13-21[PubMed]
  • 7. Goldsmith RJ, Ries RK. Principles of Addiction Medicine. 2003; : 1263-76
  • 8. Collins RL, Parks GA, Marlatt GA. Social determinants of alcohol consumption: the effects of social interaction and model status on the self-administration of alcohol. J Consult Clin Psychol. 1985; 53(2): 189-200[PubMed]
  • 9. Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002; 59(4): 375-80[PubMed]
  • 10.
  • 11. Balhara YP, Ranjan R, Dhawan A, Yadav D. Experiences from a community based substance use treatment centre in an urban resettlement colony in India. J Addict. 2014; 2014: 982028[DOI][PubMed]
  • 12. Smyth BP, Barry J, Keenan E, Ducray K. Lapse and relapse following inpatient treatment of opiate dependence. Ir Med J. 2010; 103(6): 176-9[PubMed]
  • 13. Hakansson A, Hallen E. Predictors of dropout from inpatient opioid detoxification with buprenorphine: a chart review. J Addict. 2014; 2014: 965267[DOI][PubMed]
  • 14. Majumder P, Sarkar S, Gupta R, Patra BN, Balhara YP. Predictors of retention in treatment in a tertiary care de-addiction center. Indian J Psychiatry. 2016; 58(1): 27-30[DOI][PubMed]
  • 15. Childress AR, Ehrman R, McLellan AT, MacRae J, Natale M, O'Brien CP. Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat. 1994; 11(1): 17-23[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments